Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis Analysis and Forecast by 2021

Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis Analysis and Forecast by 2021

Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis Analysis and Forecast by 2021

Comments Off on Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis Analysis and Forecast by 2021

According to the report, the global hemostasis products market was valued at approximately USD 5.30 billion in 2015 and is expected to reach approximately USD 6.70 billion by 2021, growing at a CAGR of around 4.0% between 2016 and 2021.Hemostasis is a process which helps to cease the bleeding and keep blood within a damaged blood vessel. Hemostasis products are medical products used to stop bleeding and hemorrhage caused by injuries and surgical procedures. These products vary based on their mechanism of action, ease of application, composition, immunogenicity, adherence to tissue, and cost.

[wptab name=’Report Description’ active=”1″ ]

According to the report, the global hemostasis products market was valued at approximately USD 5.30 billion in 2015 and is expected to reach approximately USD 6.70 billion by 2021, growing at a CAGR of around 4.0% between 2016 and 2021.

Hemostasis is the process which helps to stop the bleeding from a cut or injury. Hemostasis products are designed to cease bleeding and hemorrhage caused by injuries and surgical procedures. Hemostasis involves forming a clot at the site of the damaged blood vessel and repairing the blood vessel. These products vary based on their ease of application, mechanism of action, adherence to tissue, composition, immunogenicity and cost.

The hemostasis product market is mainly driven by increasing demand supported by the rise in a number of surgery volumes. Furthermore, increasing geriatric population base coupled with rising incidences of chronic conditions are other impact hemostasis product market. According to the CDC statistics, more than 45% of the American population suffers from at least one chronic condition requiring important care. On the other hand, slow adoption of advanced hemostasis devices in emerging economies and the high cost of devices are expected to curb the market growth within the forecast period. Nevertheless, emerging market in developing countries is expected to open up new growth opportunities over the next few years.

Global Hemostasis Products Market

Based on products, the hemostasis product market can be segmented into topical hemostasis, infusible hemostasis, and advanced hemostasis. The topical hemostasis are further classified into collagen, oxidized regenerated cellulose, gelatin, and polysaccharide. Infusible hemostasis includes platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex. In 2015, hemostasis product market dominated by topical hemostats segment. Topical hemostatis are generally used in adjunction with conventional treatment to provide minimal tissue reactivity, quick and easy absorbability of the hemostatic agent, and cost-efficiency. Moreover, infusible hemostasis and advanced hemostasis segments are anticipated to exhibit significant growth in the coming years.

The hemostasis product market can be segmented on the basis of applications such as trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Surgery segment was the largest segment in 2015. Bleeding control is an important aim in surgery. Thus, this segment is expected to witness substantial growth during the forecast period.  Trauma was another key outlet of this market and is anticipated to show strong growth in the years to come. More than 80% of trauma deaths that occur in the operating room do so as a result of hemorrhage. Traumatic injury is a major global health problem, accounting for approximately 1 in 10 deaths worldwide.

North America held the largest market share for hemostasis products in 2015. The dominance of the region was primarily due to increase health expenditure and technological advancement to provide innovative products. The increase in numbers of trauma cases and complex surgeries, growth geriatric population and high investment is research and development is also driving the hemostasis products market in North America. North America was followed by Asia Pacific which was another leading regional market in 2015. This growth is mainly due to increase aging population and advanced healthcare facilities. Latin America is also projected to expand at a noticeable growth rate during the forecast period.

Some of the key players operating in this market such as Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A.,  CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.

[/wptab]

[wptab name=’Table of content’]

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global hemostasis products market, 2015 – 2021 (USD Billion)
    • 2.2. Global hemostasis products market : Snapshot
  • Chapter 3. Hemostasis Products – Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global hemostasis products market drivers: Impact
      • 3.2.2. Increasing number of trauma and surgical cases
    • 3.3. Market restraints
      • 3.3.1. Global hemostasis products market restraints: Impact analysis
      • 3.3.2. Stringent regulatory policies
    • 3.4. Opportunities
      • 3.4.1. Emerging market in developing countries
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by application segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Hemostasis Products Market – Competitive Landscape
    • 4.1. Company Market Share Analysis(Subject to data Availability)
      • 4.1.1. Global hemostasis products market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
  • Chapter 5. Global Hemostasis Products Market – Product Segment Analysis
    • 5.1. Global hemostasis products market: Product overview
      • 5.1.1. Global hemostasis products market revenue share, by product, 2015 and 2021
    • 5.2. Topical Hemostasis
      • 5.2.1. Global topical hemostasis market , 2015 – 2021(USD Billion)
    • 5.3. Infusible hemostasis
      • 5.3.1. Global infusible hemostasis market , 2015 – 2021(USD Billion)
    • 5.4. Advanced Hemostasis
      • 5.4.1. Global advanced hemostasis market , 2015 – 2021(USD Billion)
  • Chapter 6. Global Hemostasis Products Market – Application Segment Analysis
    • 6.1. Global hemostasis products market: Application overview
      • 6.1.1. Global hemostasis products market revenue share, by application, 2015 and 2020
    • 6.2. Trauma
      • 6.2.1. Global hemostasis products market for trauma, 2015 – 2021 (USD Billion)
    • 6.3. Surgery
      • 6.3.1. Global hemostasis products market for surgery, 2015 – 2021(USD Billion)
    • 6.4. Hemophilia
      • 6.4.1. Global hemostasis products market for hemophilia, 2015 – 2021 (USD Billion)
    • 6.5. Myocardial infarction
      • 6.5.1. Global hemostasis products market for myocardial infarction, 2015 – 2021(USD Billion)
    • 6.6. Stroke
      • 6.6.1. Global hemostasis products market for stroke, 2015 – 2021(USD Billion)
    • 6.7. Thrombosis
      • 6.7.1. Global hemostasis products market for thrombosis, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Hemostasis Products Market – Regional Segment Analysis
    • 7.1. Global hemostasis products market: Regional overview
      • 7.1.1. Global hemostasis products market revenue share, by region, 2015 and 2021
    • 7.2. North America
      • 7.2.1. North America hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
      • 7.2.2. North America hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.2.3.2. U.S. hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
      • 7.3.2. Europe hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.3.2. Germany hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.4.2. France hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.5.2. UK hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific hemostasis products market revenue, by product, 2015 – 2021, (USD Billion)
      • 7.4.2. Asia Pacific hemostasis products market revenue, by application, 2015 – 2021, (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.3.2. China hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.4.2. Japan hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.5.2. India hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
      • 7.5.2. Latin America hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
        • 7.5.3.2. Brazil hemostasis products market revenue, by application, 2015 – 2021 (USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa hemostasis products market revenue, by product, 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East and Africa hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Pfizer, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Medtronic plc
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Abbott Laboratories
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Johnson & Johnson
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Integra LifeSciences Corporation
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. HemCon Medical Technologies, Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Grifols, S.A.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. CSL Behring LLC
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. C. R. Bard, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Baxter International, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global hemostasis products market revenue, 2015 – 2021(USD Billion)
4. Porter’s five forces analysis
5. Medical aesthetic devices: Market attractiveness analysis, by product segment
6. Medical aesthetic devices: Market attractiveness analysis, by application segment
7. Medical aesthetic devices: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015
9. Global hemostasis products market revenue share by product, 2015 and 2021
10. Global topical hemostasis market, 2015 – 2021 (USD Billion)
11. Global infusible hemostasis market, 2015 – 2021(USD Billion)
12. Global facial aesthetic devices market, 2015 – 2021 (USD Billion)
13. Global hemostasis products market revenue share by application, 2015 and 2021
14. Global hemostasis products market for trauma, 2015 – 2021, (USD Billion)
15. Global hemostasis products market for surgery, 2015 – 2021, (USD Billion)
16. Global hemostasis products market for hemophilia, 2015 – 2021, (USD Billion)
17. Global hemostasis products market for myocardial infarction, 2015 – 2021, (USD Billion)
18. Global hemostasis products market for hair removal, 2015 – 2021, (USD Billion)


List of Tables

1. Hemostasis products market: Market snapshot
2. Drivers of global hemostasis products market: Impact analysis
3. Restraints of global hemostasis products market: Impact analysis
4. North America hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
5. North America hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
6. U.S. hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
7. U.S. hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
8. Germany hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
9. Germany hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
10. France hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
11. France hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
12. UK hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
13. UK hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
14. Asia Pacific hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
15. Asia Pacific hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
16. China hemostasis products market revenue, by product 2015 – 2021(USD Billion)
17. China hemostasis products market revenue, by application 2015 – 2021(USD Billion)
18. Japan hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
19. Japan hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
20. India hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
21. India hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
22. Latin America hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
23. Latin America hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
24. Brazil hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
25. Brazil hemostasis products market revenue, by application, 2015 – 2021(USD Billion)
26. Middle East and Africa hemostasis products market revenue, by product, 2015 – 2021(USD Billion)
27. Middle East and Africa hemostasis products market revenue, by application, 2015 – 2021(USD Billion)

[/wptab]

[wptab name=’Request For Sample’]

 

[contact-form-7 id=”7″ title=”Request For Sample”]

 

[/wptab]

 

[end_wptabset]

Related Posts

Global Retinal Surgery Devices Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Comments Off on Global Retinal Surgery Devices Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents, Renal Artery Stents, Carotid Artery Stents and Forecast, 2015 – 2021

Comments Off on Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents, Renal Artery Stents, Carotid Artery Stents and Forecast, 2015 – 2021

mHealth Market by Devices, by Stakeholder, by Service, by Therapeutics and by Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2022

Comments Off on mHealth Market by Devices, by Stakeholder, by Service, by Therapeutics and by Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2022

Cardiovascular Monitoring and Diagnostic Devices Market by Product Type (ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders, Analysis and Forecast, 2015 – 2021

Comments Off on Cardiovascular Monitoring and Diagnostic Devices Market by Product Type (ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders, Analysis and Forecast, 2015 – 2021

Gastrointestinal Endoscopic Devices Market: Hemostatis Devices, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopes, GI Videoscopes, and Others: Forecast, 2015 – 2021

Comments Off on Gastrointestinal Endoscopic Devices Market: Hemostatis Devices, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopes, GI Videoscopes, and Others: Forecast, 2015 – 2021

Ultrasound Devices Market by Technology (Doppler Ultrasound Imaging, High Intensity Focused Ultrasound (HIFU), 2-D Ultrasound Imaging, 3-D and 4-D Ultrasound Imaging, and Lithotripsy Ultrasound Imaging) Market for Cardiovascular, Obstetrics and Gynecology, Gastroenterology, Radiology Trends and Forecast, 2015 – 2021

Comments Off on Ultrasound Devices Market by Technology (Doppler Ultrasound Imaging, High Intensity Focused Ultrasound (HIFU), 2-D Ultrasound Imaging, 3-D and 4-D Ultrasound Imaging, and Lithotripsy Ultrasound Imaging) Market for Cardiovascular, Obstetrics and Gynecology, Gastroenterology, Radiology Trends and Forecast, 2015 – 2021

Global Respiratory Disease Testing Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Comments Off on Global Respiratory Disease Testing Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global Implantable Drug Delivery Devices Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Comments Off on Global Implantable Drug Delivery Devices Market – Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Mobile Device Management Market by Solutions (Device Management, Deployment Management, Security Management, Network Service Management, and Trends 2021

Comments Off on Mobile Device Management Market by Solutions (Device Management, Deployment Management, Security Management, Network Service Management, and Trends 2021

Revenue Cycle Management Market by Product (Integrated and Standalone) by Component (Services and Software) and by Deployment (Web-Based On-Premise and Cloud-Based Systems) For Physician, Hospitals, Medical and Diagnostic Laboratories, and Others Trends and Forecast by 2022

Comments Off on Revenue Cycle Management Market by Product (Integrated and Standalone) by Component (Services and Software) and by Deployment (Web-Based On-Premise and Cloud-Based Systems) For Physician, Hospitals, Medical and Diagnostic Laboratories, and Others Trends and Forecast by 2022

Spine Surgery Devices Market by Technology Type (Fusion Non-Fusion, Vertebral Compression Fracture, Spine Biologics and Size, Share 2021

Comments Off on Spine Surgery Devices Market by Technology Type (Fusion Non-Fusion, Vertebral Compression Fracture, Spine Biologics and Size, Share 2021

Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin and Forecast, 2015 – 2021

Comments Off on Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin and Forecast, 2015 – 2021

Create Account



Log In Your Account